APLS vs VICI · rev $781.4M vs P/E 9.3, rev $2.08B
Apellis Pharmaceuticals Inc (APLS) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported VICI revenue for 2026-06-30 was $2.08B. Net income was $1.40B. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
APLS currently screens at market cap $2.29B. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the APLS and VICI stock pages for the full models.
Not investment advice.